# US 2024/0189580 A1 · Stimulation leads and systems for cancer treatment with low resistance and heat generation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189580 A1
- Document ID: US20240189580A1
- Status: Published application
- Kind: A1
- Application number: 18/530,935
- Filed: 2023-12-06
- Published: 2024-06-13
- Earliest claimed: 2022-12-07
- Assignees: Mayo Foundation for Medical Education and Research
- Applicants: Cardiac Pacemakers, Inc.
- Inventors: Devon N. Arnholt; Michael J. Kane; Brian L. Schmidt
- Web page: https://patentgrep.com/patent/US20240189580A1

## CPC

- A61N 1/0526: {Head electrodes (A61N1/0551 takes precedence)}
- A61N 1/36002: {Cancer treatment, e.g. tumour}
- A61N 1/048: {Electrodes characterised by a specific connection between lead and electrode}
- A61N 1/0488: {Details about the lead}
- A61N 1/05: for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence)
- A61N 1/40: Applying electric fields by inductive or capacitive coupling (microwave apparatus A61N5/00); {Applying radio-frequency signals}
- A61N 1/0529: {Electrodes for brain stimulation}
- A61N 1/0534: {Electrodes for deep brain stimulation}
- A61N 1/3606: {adapted for a particular treatment}
- A61N 1/36139: {with automatic adjustment}
- A61N 1/36171: {Frequency}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Embodiments herein relate to implantable cancer therapy systems and stimulation leads thereof with low resistance. In an embodiment, an implantable lead for a cancer treatment system is included having a lead body with a proximal end and a distal end and one or more electric field generating electrodes. The electrodes are disposed along a length of the lead body. A plurality of electrical wires are included and disposed within the lead body. The plurality of electrical wires provides an electrical connection between at least one of the electrodes and the proximal end of the lead body. At least two of the plurality of electrical wires are arranged in parallel and connected to the same electrode. Other embodiments are also included herein.

## Claims

### Claim 1

An implantable lead for a cancer treatment system comprising:
a lead body, the lead body comprising
a proximal end; and
a distal end;
one or more electric field generating electrodes, wherein the electrodes are disposed along a length of the lead body;
a plurality of electrical wires;
wherein the plurality of electrical wires are disposed within the lead body;
wherein the plurality of electrical wires provide an electrical connection between at least one of the electrodes and the proximal end of the lead body; and
wherein at least two of the plurality of electrical wires are arranged in parallel and connected to the same electrode.

### Claim 2 (depends on 1)

The implantable lead for a cancer treatment system of claim 1, the electrodes comprising:
a proximal end; and
a distal end; and
wherein the plurality of electrical wires arranged in parallel are connected to a middle portion of the electrodes between the proximal end and the distal end.

### Claim 3 (depends on 1)

The implantable lead for a cancer treatment system of claim 1, wherein a set of the plurality of electrical wires reflecting all wires connected to a particular electrode of the one or more electric field generating electrodes have a resistance of less than 0.4 ohm/cm.

### Claim 4 (depends on 1)

The implantable lead for a cancer treatment system of claim 1, wherein a set of the plurality of electrical wires reflecting all wires connected to a particular electrode of the one or more electric field generating electrodes have a resistance of less than or equal to 0.2 ohm/cm.

### Claim 5 (depends on 1)

The implantable lead for a cancer treatment system of claim 1, further comprising:
a connection plug, the connection plug comprising a plurality of electrical terminals;
wherein the connection plug is disposed at the proximal end of the lead body; and
wherein the connection plug is in electrical communication with the plurality of electrical wires.

### Claim 6 (depends on 5)

The implantable lead for a cancer treatment system of claim 5, wherein the resistance of the electrical wires arranged in parallel and connected to the same electrode as measured from an electrical terminal to a point of connection with the electrode is less than 5 ohms.

### Claim 7 (depends on 5)

The implantable lead for a cancer treatment system of claim 5, wherein the resistance of the electrical wires arranged in parallel and connected to the same electrode as measured from an electrical terminal to a point of connection with the electrode is less than or equal to 3.5 ohms.

### Claim 8 (depends on 1)

The implantable lead for a cancer treatment system of claim 1, wherein the electrodes are disposed circumferentially around the lead body and extend a distance along a longitudinal axis of the lead body.

### Claim 9 (depends on 1)

The implantable lead for a cancer treatment system of claim 1, wherein at least three of the plurality of electrical wires are arranged in parallel and connected to the same electrode.

### Claim 10 (depends on 1)

The implantable lead for a cancer treatment system of claim 1, wherein the plurality of electrical wires have a diameter of less than 130 microns.

### Claim 11 (depends on 1)

The implantable lead for a cancer treatment system of claim 1, the electrodes comprising a flat ribbon of metal, wherein the flat ribbon of metal is wrapped around the lead body.

### Claim 12 (depends on 1)

The implantable lead for a cancer treatment system of claim 1, the electrodes comprising at least two electrical field generating electrodes, wherein the at least two electrical field generating electrodes are separated by a distance along a longitudinal axis of the lead body.

### Claim 13

An implantable lead for a cancer treatment system comprising:
a lead body, the lead body comprising
a proximal end; and
a distal end;
one or more electric field generating electrodes, the electrodes comprising a plurality of discrete segments, wherein the plurality of discrete segments are electrically isolated from direct connection with one another;
wherein the electrodes are disposed along a length of the lead body;
a plurality of electrical wires;
wherein the plurality of electrical wires are disposed within the lead body;
wherein the plurality of electrical wires provide an electrical connection between the electrodes and the proximal end of the lead body; and
wherein the plurality of electrical wires are separately connected to the discrete segments of the electrodes.

### Claim 14 (depends on 13)

The implantable lead for a cancer treatment system of claim 13, wherein the plurality of discrete segments have a length along the longitudinal axis of the lead body from 0.25 to 70 mm.

### Claim 15 (depends on 13)

The implantable lead for a cancer treatment system of claim 13, wherein the plurality of discrete segments wrap around the lead body circumferentially.

### Claim 16 (depends on 13)

The implantable lead for a cancer treatment system of claim 13, further comprising a temperature sensor, wherein the temperature sensor is disposed between two adjacent discrete segments.

### Claim 17

An implantable cancer treatment system comprising:
an implantable housing, the implantable housing comprising
an electric field generating circuit; and
control circuitry;
wherein the control circuitry causes the electric field generating circuit to generate the one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz within a bodily tissue;
wherein the one or more electric fields are effective to prevent and/or disrupt cellular mitosis in a cancerous cell;
a therapy lead, the therapy lead comprising
a lead body, the lead body comprising
a proximal end; and
a distal end;
one or more electric field generating electrodes, the electrodes comprising a plurality of discrete segments, wherein the plurality of discrete segments are electrically isolated from direct connection with one another;
wherein the electrodes are disposed along a length of the lead body;
a plurality of electrical wires;
wherein the plurality of electrical wires are disposed within the lead body;
wherein the plurality of electrical wires provide an electrical connection between the electrodes and the proximal end of the lead body;
wherein the plurality of electrical wires are separately connected to the discrete segments of the electrodes; and
wherein the implantable cancer treatment system is configured to execute a duty cycle scheme wherein electrical fields are delivered using one or more individual discrete segments during a first phase of a cycle alternating with a separate one or more individual discrete segments during a second phase of the cycle.

### Claim 18 (depends on 17)

The implantable cancer treatment system of claim 17, wherein the plurality of discrete segments have a length along the longitudinal axis of the lead body from 0.25 to 70 mm.

### Claim 19 (depends on 17)

The implantable cancer treatment system of claim 17, the therapy lead further comprising a temperature sensor, wherein the temperature sensor is disposed between two adjacent discrete segments.

### Claim 20 (depends on 19)

The implantable cancer treatment system of claim 19, wherein the duty cycle scheme is modulated based on a signal from the temperature sensor.
